RxDoctor Payments Data

Yesul Kim, MD

Dermatology · Fairfield, CTNPI 1144725672

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 36.4% of the total. 2025 is the largest year on record at $355, 4.6 times the $76 reported in 2020. That places this record below the midpoint for dermatology clinicians in CT, where the typical reported total is $3,198.

$1,140in general payments, 2019–2025

Across 42 payments — averaging $27.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$415
  • Organogenesis Inc.$145
  • Sun Pharmaceutical Industries Inc.$109
  • Arcutis Biotherapeutics, Inc.$83
  • Revance Therapeutics, Inc.$60
  • Incyte Corporation$60
  • plus $267 from 10 others

What the payments were for

  • Food & beverage$1,140100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,140 in reported general payments places this provider in the 35th percentile of 222 dermatology providers in Connecticut.

See all dermatology providers in Connecticut →

Medicare billing

Part B allowed, 2024
$475,068
Medicare patients
348
Services billed
1,762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate30$1,440
Triamcinolone Acetonide52$590
Doxycycline Hyclate56$584
Minoxidil22$232
Mupirocin26$201
Hydrocortisone17$138
Cephalexin27$90

Paid to pharmacies, not to this prescriber.

Other dermatology in Fairfield

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →